l-carnitine methylcobalamin and folic acid tablets brands Product L-Carnitine + Mecobalamin Tablets |

Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases

10.1194/jlr.R067595 62

If the existing information reported by manufacturers participating in the MDRP indicates that an NDC-9 does represent a new NDC-9 of a Part D rebatable drug, but there are no quarters during the period set forth in 428.202(c)(1) or (c)(2) for which AMP has been reported under section 1927(b)(3) of the Act for the NDC-9, including information as set forth in 428.202(d)(3), CMS will apply the payment amount benchmark period identification policies finalized at 428.202(c)(3) or (4), as applicable, at this time

Front Cell Dev Biol 8:611735